Allurion Technologies, Inc. Common Stock ALUR 深 滬
等待開盤 08-08 09:30:00 美东时间
2.76
-0.070
-2.47%
華盛通- 最 高2.86
- 今 開2.83
- 成交量 3.47万股
- 最 低 2.7391
- 昨 收 2.83
- 總市值 748.31万
- 52周最高 22.245
- 市盈率 靜 --
- 換手率 1.28%
- 52周最低 2.15
- 委 比 0.00%
- 總股本 271.13万
- 歷史最高 225.00
- 量 比 0.65
- 振 幅 4.27%
- 歷史最低 2.7391
- 每 手 1
- 風險率 6.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Watching Allurion Technologies; Shares See Volume To The Upside, Traders Circulate X Post Saying "New Publication In The Obesity Surgery Journal About The Allurion Swallowable Gastric Balloon Program Titled 'Weight Loss Maintenance 1 Year After The Swallowable Gastric Balloon: Results From An International Multicenter Study'"
https://link.springer.com/article/10.1007/s11695-025-08074-2
07-18 23:11
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
Gainers Mullen Automotive (NASDAQ:MULN) stock rose 41.4% to $0.32 during Monda...
07-07 20:07
Allurion Technologies shares are trading higher after the company announced the presentation of a study entitled "The Swallowable Gastric Balloon Program with AI Powered Health Coach Leads to Metabolically Healthy Weight Loss in French Patients," that assessed 1,962 patients in France treated with the Allurion Program.
Allurion Technologies shares are trading higher after the company announced the...
05-28 04:14
Allurion Technologies Earnings Call: Transition and Growth
Allurion Technologies, Inc. (($ALUR)) has held its Q1 earnings call. Read on fo...
05-16 10:20
Allurion Technologies Q1 Adj. EPS $0.24 Beats $(8.58) Estimate, Sales $5.58M Beat $5.50M Estimate
Allurion Technologies (NYSE:ALUR) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(8.58) by 102.8 percent. This is a 91.27 percent decrease over earnings of $2.75 per share
05-14 20:39
Allurion Technologies Affirms FY2025 Sales Guidance of $30.00M vs $40.20M Est
Allurion Technologies (NYSE:ALUR) affirms FY2025 sales outlook from $30.00 million to $30.00 million vs $40.20 million estimate.
05-14 20:14
Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Everus Construction Group, Inc. (NYSE:ECG) rose sharply in today's pr...
05-14 17:20
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
Earnings Outlook For Allurion Technologies
Allurion Technologies (NYSE:ALUR) is set to give its latest quarterly earnings ...
05-14 02:03
美股大行评级 | 潜在涨幅345.1%！Corvus Pharma获Oppenheimer升目标价至15美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112300378952404993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Corvus Pharma(CRVS)"跑赢大市"评级，目标价从14美元升至15美元</p> <p>• 富国银行：上调Regulus Therapeutics(RGLS)评级至"超配"，目标价从
03-28 09:06
